JointHealth™ express February 1, 2018
Biosimilars in Canada: What inflammatory arthritis patients need to know
Arthritis Consumer Experts (ACE) is pleased to announce the publication of its latest educational webinar titled “Biosimilars in Canada: What inflammatory arthritis patients need to know”. Co-presented by Dr. John Esdaile, Scientific Director, Arthritis Research Canada and Ms. Cheryl Koehn, Founder and President, Arthritis Consumer Experts, the webinar covers the latest biosimilar research, patient education information and public drug plan reimbursement policy development:
Click here to view this important new webinar in our educational series. We also encourage you to visit ACE’s Biosimilar•Exchange, the world’s only patient written, research informed web site on biosimilars – free from commercial bias or branding.
Biosimilars in Canada: What inflammatory arthritis patients need to know
Arthritis Consumer Experts (ACE) is pleased to announce the publication of its latest educational webinar titled “Biosimilars in Canada: What inflammatory arthritis patients need to know”. Co-presented by Dr. John Esdaile, Scientific Director, Arthritis Research Canada and Ms. Cheryl Koehn, Founder and President, Arthritis Consumer Experts, the webinar covers the latest biosimilar research, patient education information and public drug plan reimbursement policy development:
- Safety, efficacy and immunogenicity
- Latest clinical research
- Clinical and patient experiences
- Safety and efficacy monitoring
- Medical and policy transitioning
- Societal benefit
Click here to view this important new webinar in our educational series. We also encourage you to visit ACE’s Biosimilar•Exchange, the world’s only patient written, research informed web site on biosimilars – free from commercial bias or branding.
Arthritis Consumer Experts
ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealth™ information and education programs.